Evidence map›Paper›PMID 42478838›Full record

ArticleMicrobiology spectrum2026

Association between antimicrobial regimens and 28-day mortality in patients with

Shumin Gu, Xinyu Liu, Wenjing Lu, Shuzheng Du, Longhua Hu, Yunwei Zheng, Xingwei Cao, Yaping Hang, Zihan Li, Lihua Huang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shumin Gu *Department of Clinical Laboratory, Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID 0000-0001-5442-2274
Xinyu Liu *School of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
Wenjing LuDepartment of Clinical Laboratory, Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Shuzheng DuCollege of Anesthesiology, Henan Medical University, Xinxiang, China.
Longhua HuDepartment of Clinical Laboratory, Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yunwei ZhengDepartment of Clinical Laboratory, Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Xingwei CaoDepartment of Clinical Laboratory, Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yaping HangDepartment of Clinical Laboratory, Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Zihan LiDepartment of Clinical Laboratory, Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Lihua HuangDepartment of Clinical Laboratory, Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Qiaoshi ZhongDepartment of Clinical Laboratory, Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID 0000-0002-1851-9682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IMPORTANCE:

Indexed as

Anti-Bacterial AgentsGram-Negative Bacterial InfectionsStenotrophomonas maltophiliaAgedAged, 80 and overCefoperazoneDrug Therapy, CombinationFemaleFluoroquinolonesHumansMaleMiddle AgedPropensity ScoreRetrospective StudiesSulbactamTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsCefoperazoneFluoroquinolonesSulbactamTrimethoprim, Sulfamethoxazole Drug Combination28-day mortalityantimicrobial therapycefoperazone-sulbactamcombination therapyStenotrophomonas maltophiliatrimethoprim-sulfamethoxazole

Identifiers

PMID42478838
PMCPMC13532249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.